Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Specialized Stain Enables Exceptional Bone Marrow Diagnostic Pathology

By LabMedica International staff writers
Posted on 13 Mar 2014
A new tissue stain has been specially developed to provide superior clarity of differentiation and detail in bone marrow tissue samples for disease diagnosis. More...


Dako (Glostrup, Denmark), an Agilent Technologies (Santa Clara, CA, USA) company, has now added its new Jenner-Wright Giemsa stain to Dako's broad palette of automated stains – its Artisan Link portfolio. Dako is releasing the stain in its continuing mission to provide pathology labs with the most advanced special stain solutions and the broadest portfolio.

The Jenner-Wright Giemsa stain is designed to give pathologists an added dimension to the visualization of the cell morphology by providing clear differentiation and detail of hematopoietic cells in bone marrow samples for the diagnosis of diseases, such as cancer, aplastic anemia, and myelofibrosis.

The Artisan portfolio provides the broadest range of automated special stains available—currently consisting of 31 high-quality stains, covering most of a typical laboratory’s special stain needs. Dako also plans to add more stains to the portfolio.

The portfolio also enables labs to take advantage of the productivity benefits possible through automation with the Artisan Link Pro instrument. Laboratories that routinely do special stains will benefit from a 64% reduction in hands-on time with Artisan Link Pro, compared with the same protocols performed manually. Significant gains in lab safety can be realized because the Artisan Link Pro and its ready-to-use reagents are closed, minimizing exposure to hazardous chemicals, and can be connected to ventilation systems. The instrument also features a unique waste separation system that reduces hazardous waste generation, helping labs minimize disposal and associated costs.

"Dako’s Jenner-Wright Giemsa special stain for bone marrow is excellent, and allows us, for the first time, to automate the diagnosis of various diseases using bone marrow tissue," said Prof. Hermann Herbst, director of the Vivantes Pathology Department in Berlin. "Artisan Link Pro stains are fabulous to look at. This stain in particular offers an unprecedented ability to use bone marrow and provides exceptionally clear differentiation and detail."

Related Links:

Dako
Dako's Jenner-Wright Giemsa kit
Agilent Technologies 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.